CSIMarket
Biomarin Pharmaceutical Inc  (BMRN)
Other Ticker:  
 
 

Biomarin Pharmaceutical Inc's Yearly Income from Continued Operations Growth 5 Years

 

Select the Comparisons : Select the Ratio:



BMRN Annual Income from Cont. Operations Growth

2023
2022
2021
2020
2019
Y / Y Annual Income from Cont. Operations Change 18.43 % - - - -
Annual Income from Cont. Operations (in millions $) $167.65 $141.56 $-64.08 $859.10 $-23.85


Annual Income from Cont. Operations Growth Comment
Biomarin Pharmaceutical Inc's Annual Income from Cont. Operations for the fiscal year ended 2023, grew by 18.43% to $167.65 millions, from $141.56 millions achieved a year ago. Biomarin Pharmaceutical Inc's growrh rate for Income from Continued Operations improved from -320.91 % decline in the fiscal year 2022.

Biomarin Pharmaceutical Inc Annual Income Statement




You need to upgrade your Flash Player



Companies with similar 2023 Annual Income from Cont. Operations within Healthcare SectorY/Y Income from Continued Operations Growth %2023 Annual Income from Cont. Operations
Merck and Co Inc -97.49 %$ 365.000  millions
Biontech Se -90.14 %$ 1,041.936  millions
Biogen Inc -60.78 %$ 1,161.500  millions
Viatris Inc -97.37 %$ 54.700  millions
Becton Dickinson And Company -6.42 %$ 1,530.000  millions
Edwards Lifesciences Corporation -8.05 %$ 1,399.400  millions
Hologic Inc -64.98 %$ 456.000  millions
Agilent Technologies inc -1.12 %$ 1,240.000  millions
Iqvia Holdings Inc   24.47 %$ 1,358.000  millions
Quest Diagnostics Inc -10.54 %$ 908.000  millions
Fresenius Medical Care Ag -18.10 %$ 820.353  millions
Tenet Healthcare Corp  31.10 %$ 1,311.000  millions
Organon and Co   11.56 %$ 1,023.000  millions
Mettler toledo International Inc -9.60 %$ 788.778  millions
Resmed Inc   15.15 %$ 897.556  millions
Davita Inc   24.58 %$ 956.978  millions
United Therapeutics Corporation  35.40 %$ 984.800  millions
Boston Scientific Corporation  128.08 %$ 1,592.000  millions
Avantor Inc -53.23 %$ 321.100  millions
Idexx Laboratories Inc  24.44 %$ 845.042  millions
West Pharmaceutical Services Inc   1.28 %$ 593.400  millions
Henry Schein Inc -22.97 %$ 436.000  millions
Vir Biotechnology Inc